Organism 101348 -

Property	Value
Family
Genus
Species
Species authority
Subspecies
Subspecies authority
Comment
Citation	ZHU,M: PHILLIPSON,JD: GREENGRASS,PM: BOWERY,NE: CAI,Y:. (1997). PLANT POLYPHENOLS:BIOLOGICALLY ACTIVE COMPOUNDS OR NON-SELECTIVE BINDERS TO PROTEIN?. 44(3)

320 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
366066	PHARMACOLOGY OF COMPOUND - IN VITRO	ATP-ASE (NA+/K+) BINDING ACTIVITY	Empty organism	CATECHIN,(+):
366067	PHARMACOLOGY OF COMPOUND - IN VITRO	SPHINGOMYELINASE INHIBITION	Empty organism	CATECHIN,(+):
366068	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZODIAZEPINE BINDING INHIBITION	Empty organism	CATECHIN,(+):
366069	PHARMACOLOGY OF COMPOUND - IN VITRO	OPIATE RECEPTOR BINDING INHIBITION	Empty organism	CATECHIN,(+):
366070	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	CATECHIN,(+):
366071	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	CATECHIN,(+):
366072	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	CATECHIN,(+):
366073	PHARMACOLOGY OF COMPOUND - IN VITRO	MUSCARINIC RECEPTOR BINDING ACTIVITY	Empty organism	CATECHIN,(+):
366074	PHARMACOLOGY OF COMPOUND - IN VITRO	CALCIUM CHANNEL BINDING EFFECT	Empty organism	CATECHIN,(+):
366075	PHARMACOLOGY OF COMPOUND - IN VITRO	SULFONYLUREA RECEPTOR BINDING ACTIVITY	Empty organism	CATECHIN,(+):
366076	PHARMACOLOGY OF COMPOUND - IN VITRO	ADENOSINE A-1 RECEPTOR BINDING INHIBITION	Empty organism	CATECHIN,(+):
366077	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	CATECHIN,(+):
366078	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	CATECHIN,(+):
366079	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-1)	Empty organism	CATECHIN,(+):
366080	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-2)	Empty organism	CATECHIN,(+):
366081	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(BETA)	Empty organism	CATECHIN,(+):
366082	PHARMACOLOGY OF COMPOUND - IN VITRO	ATP-ASE (NA+/K+) BINDING ACTIVITY	Empty organism	GALLOCATECHIN,(+):
366083	PHARMACOLOGY OF COMPOUND - IN VITRO	SPHINGOMYELINASE INHIBITION	Empty organism	GALLOCATECHIN,(+):
366084	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZODIAZEPINE BINDING INHIBITION	Empty organism	GALLOCATECHIN,(+):
366085	PHARMACOLOGY OF COMPOUND - IN VITRO	OPIATE RECEPTOR BINDING INHIBITION	Empty organism	GALLOCATECHIN,(+):
366086	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GALLOCATECHIN,(+):
366087	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GALLOCATECHIN,(+):
366088	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GALLOCATECHIN,(+):
366089	PHARMACOLOGY OF COMPOUND - IN VITRO	MUSCARINIC RECEPTOR BINDING ACTIVITY	Empty organism	GALLOCATECHIN,(+):
366090	PHARMACOLOGY OF COMPOUND - IN VITRO	CALCIUM CHANNEL BINDING EFFECT	Empty organism	GALLOCATECHIN,(+):
366091	PHARMACOLOGY OF COMPOUND - IN VITRO	SULFONYLUREA RECEPTOR BINDING ACTIVITY	Empty organism	GALLOCATECHIN,(+):
366092	PHARMACOLOGY OF COMPOUND - IN VITRO	ADENOSINE A-1 RECEPTOR BINDING INHIBITION	Empty organism	GALLOCATECHIN,(+):
366093	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	GALLOCATECHIN,(+):
366094	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	GALLOCATECHIN,(+):
366095	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-1)	Empty organism	GALLOCATECHIN,(+):
366096	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-2)	Empty organism	GALLOCATECHIN,(+):
366097	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(BETA)	Empty organism	GALLOCATECHIN,(+):
366098	PHARMACOLOGY OF COMPOUND - IN VITRO	ATP-ASE (NA+/K+) BINDING ACTIVITY	Empty organism	CATECHIN-3-O-GALLATE
366099	PHARMACOLOGY OF COMPOUND - IN VITRO	SPHINGOMYELINASE INHIBITION	Empty organism	CATECHIN-3-O-GALLATE
366100	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZODIAZEPINE BINDING INHIBITION	Empty organism	CATECHIN-3-O-GALLATE
366101	PHARMACOLOGY OF COMPOUND - IN VITRO	OPIATE RECEPTOR BINDING INHIBITION	Empty organism	CATECHIN-3-O-GALLATE
366102	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	CATECHIN-3-O-GALLATE
366103	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	CATECHIN-3-O-GALLATE
366104	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	CATECHIN-3-O-GALLATE
366105	PHARMACOLOGY OF COMPOUND - IN VITRO	MUSCARINIC RECEPTOR BINDING ACTIVITY	Empty organism	CATECHIN-3-O-GALLATE
366106	PHARMACOLOGY OF COMPOUND - IN VITRO	CALCIUM CHANNEL BINDING EFFECT	Empty organism	CATECHIN-3-O-GALLATE
366107	PHARMACOLOGY OF COMPOUND - IN VITRO	SULFONYLUREA RECEPTOR BINDING ACTIVITY	Empty organism	CATECHIN-3-O-GALLATE
366108	PHARMACOLOGY OF COMPOUND - IN VITRO	ADENOSINE A-1 RECEPTOR BINDING INHIBITION	Empty organism	CATECHIN-3-O-GALLATE
366109	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	CATECHIN-3-O-GALLATE
366110	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	CATECHIN-3-O-GALLATE
366111	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-1)	Empty organism	CATECHIN-3-O-GALLATE
366112	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-2)	Empty organism	CATECHIN-3-O-GALLATE
366113	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(BETA)	Empty organism	CATECHIN-3-O-GALLATE
366114	PHARMACOLOGY OF COMPOUND - IN VITRO	ATP-ASE (NA+/K+) BINDING ACTIVITY	Empty organism	AFZELECHIN,EPI:
366115	PHARMACOLOGY OF COMPOUND - IN VITRO	SPHINGOMYELINASE INHIBITION	Empty organism	AFZELECHIN,EPI:
366116	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZODIAZEPINE BINDING INHIBITION	Empty organism	AFZELECHIN,EPI:
366117	PHARMACOLOGY OF COMPOUND - IN VITRO	OPIATE RECEPTOR BINDING INHIBITION	Empty organism	AFZELECHIN,EPI:
366118	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	AFZELECHIN,EPI:
366119	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	AFZELECHIN,EPI:
366120	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	AFZELECHIN,EPI:
366121	PHARMACOLOGY OF COMPOUND - IN VITRO	MUSCARINIC RECEPTOR BINDING ACTIVITY	Empty organism	AFZELECHIN,EPI:
366122	PHARMACOLOGY OF COMPOUND - IN VITRO	CALCIUM CHANNEL BINDING EFFECT	Empty organism	AFZELECHIN,EPI:
366123	PHARMACOLOGY OF COMPOUND - IN VITRO	SULFONYLUREA RECEPTOR BINDING ACTIVITY	Empty organism	AFZELECHIN,EPI:
366124	PHARMACOLOGY OF COMPOUND - IN VITRO	ADENOSINE A-1 RECEPTOR BINDING INHIBITION	Empty organism	AFZELECHIN,EPI:
366125	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	AFZELECHIN,EPI:
366126	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	AFZELECHIN,EPI:
366127	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-1)	Empty organism	AFZELECHIN,EPI:
366128	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-2)	Empty organism	AFZELECHIN,EPI:
366129	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(BETA)	Empty organism	AFZELECHIN,EPI:
366130	PHARMACOLOGY OF COMPOUND - IN VITRO	ATP-ASE (NA+/K+) BINDING ACTIVITY	Empty organism	CATECHIN,EPI: (-):
366131	PHARMACOLOGY OF COMPOUND - IN VITRO	SPHINGOMYELINASE INHIBITION	Empty organism	CATECHIN,EPI: (-):
366132	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZODIAZEPINE BINDING INHIBITION	Empty organism	CATECHIN,EPI: (-):
366133	PHARMACOLOGY OF COMPOUND - IN VITRO	OPIATE RECEPTOR BINDING INHIBITION	Empty organism	CATECHIN,EPI: (-):
366134	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	CATECHIN,EPI: (-):
366135	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	CATECHIN,EPI: (-):
366136	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	CATECHIN,EPI: (-):
366137	PHARMACOLOGY OF COMPOUND - IN VITRO	MUSCARINIC RECEPTOR BINDING ACTIVITY	Empty organism	CATECHIN,EPI: (-):
366138	PHARMACOLOGY OF COMPOUND - IN VITRO	CALCIUM CHANNEL BINDING EFFECT	Empty organism	CATECHIN,EPI: (-):
366139	PHARMACOLOGY OF COMPOUND - IN VITRO	SULFONYLUREA RECEPTOR BINDING ACTIVITY	Empty organism	CATECHIN,EPI: (-):
366140	PHARMACOLOGY OF COMPOUND - IN VITRO	ADENOSINE A-1 RECEPTOR BINDING INHIBITION	Empty organism	CATECHIN,EPI: (-):
366141	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	CATECHIN,EPI: (-):
366142	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	CATECHIN,EPI: (-):
366143	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-1)	Empty organism	CATECHIN,EPI: (-):
366144	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-2)	Empty organism	CATECHIN,EPI: (-):
366145	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(BETA)	Empty organism	CATECHIN,EPI: (-):
366146	PHARMACOLOGY OF COMPOUND - IN VITRO	ATP-ASE (NA+/K+) BINDING ACTIVITY	Empty organism	GALLOCATECHIN,EPI: (-):
366147	PHARMACOLOGY OF COMPOUND - IN VITRO	SPHINGOMYELINASE INHIBITION	Empty organism	GALLOCATECHIN,EPI: (-):
366148	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZODIAZEPINE BINDING INHIBITION	Empty organism	GALLOCATECHIN,EPI: (-):
366149	PHARMACOLOGY OF COMPOUND - IN VITRO	OPIATE RECEPTOR BINDING INHIBITION	Empty organism	GALLOCATECHIN,EPI: (-):
366150	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GALLOCATECHIN,EPI: (-):
366151	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GALLOCATECHIN,EPI: (-):
366152	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GALLOCATECHIN,EPI: (-):
366153	PHARMACOLOGY OF COMPOUND - IN VITRO	MUSCARINIC RECEPTOR BINDING ACTIVITY	Empty organism	GALLOCATECHIN,EPI: (-):
366154	PHARMACOLOGY OF COMPOUND - IN VITRO	CALCIUM CHANNEL BINDING EFFECT	Empty organism	GALLOCATECHIN,EPI: (-):
366155	PHARMACOLOGY OF COMPOUND - IN VITRO	SULFONYLUREA RECEPTOR BINDING ACTIVITY	Empty organism	GALLOCATECHIN,EPI: (-):
366156	PHARMACOLOGY OF COMPOUND - IN VITRO	ADENOSINE A-1 RECEPTOR BINDING INHIBITION	Empty organism	GALLOCATECHIN,EPI: (-):
366157	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	GALLOCATECHIN,EPI: (-):
366158	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	GALLOCATECHIN,EPI: (-):
366159	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-1)	Empty organism	GALLOCATECHIN,EPI: (-):
366160	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-2)	Empty organism	GALLOCATECHIN,EPI: (-):
366161	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(BETA)	Empty organism	GALLOCATECHIN,EPI: (-):
366162	PHARMACOLOGY OF COMPOUND - IN VITRO	ATP-ASE (NA+/K+) BINDING ACTIVITY	Empty organism	GALLOCATECHIN-3-O-GALLATE,EPI: (-):
366163	PHARMACOLOGY OF COMPOUND - IN VITRO	SPHINGOMYELINASE INHIBITION	Empty organism	GALLOCATECHIN-3-O-GALLATE,EPI: (-):
366164	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZODIAZEPINE BINDING INHIBITION	Empty organism	GALLOCATECHIN-3-O-GALLATE,EPI: (-):
366165	PHARMACOLOGY OF COMPOUND - IN VITRO	OPIATE RECEPTOR BINDING INHIBITION	Empty organism	GALLOCATECHIN-3-O-GALLATE,EPI: (-):
366166	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GALLOCATECHIN-3-O-GALLATE,EPI: (-):
366167	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GALLOCATECHIN-3-O-GALLATE,EPI: (-):
366168	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GALLOCATECHIN-3-O-GALLATE,EPI: (-):
366169	PHARMACOLOGY OF COMPOUND - IN VITRO	MUSCARINIC RECEPTOR BINDING ACTIVITY	Empty organism	GALLOCATECHIN-3-O-GALLATE,EPI: (-):
366170	PHARMACOLOGY OF COMPOUND - IN VITRO	CALCIUM CHANNEL BINDING EFFECT	Empty organism	GALLOCATECHIN-3-O-GALLATE,EPI: (-):
366171	PHARMACOLOGY OF COMPOUND - IN VITRO	SULFONYLUREA RECEPTOR BINDING ACTIVITY	Empty organism	GALLOCATECHIN-3-O-GALLATE,EPI: (-):
366172	PHARMACOLOGY OF COMPOUND - IN VITRO	ADENOSINE A-1 RECEPTOR BINDING INHIBITION	Empty organism	GALLOCATECHIN-3-O-GALLATE,EPI: (-):
366173	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	GALLOCATECHIN-3-O-GALLATE,EPI: (-):
366174	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	GALLOCATECHIN-3-O-GALLATE,EPI: (-):
366175	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-1)	Empty organism	GALLOCATECHIN-3-O-GALLATE,EPI: (-):
366176	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-2)	Empty organism	GALLOCATECHIN-3-O-GALLATE,EPI: (-):
366177	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(BETA)	Empty organism	GALLOCATECHIN-3-O-GALLATE,EPI: (-):
366178	PHARMACOLOGY OF COMPOUND - IN VITRO	ATP-ASE (NA+/K+) BINDING ACTIVITY	Empty organism	PROCYANIDIN B-2
366179	PHARMACOLOGY OF COMPOUND - IN VITRO	SPHINGOMYELINASE INHIBITION	Empty organism	PROCYANIDIN B-2
366180	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZODIAZEPINE BINDING INHIBITION	Empty organism	PROCYANIDIN B-2
366181	PHARMACOLOGY OF COMPOUND - IN VITRO	OPIATE RECEPTOR BINDING INHIBITION	Empty organism	PROCYANIDIN B-2
366182	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	PROCYANIDIN B-2
366183	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	PROCYANIDIN B-2
366184	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	PROCYANIDIN B-2
366185	PHARMACOLOGY OF COMPOUND - IN VITRO	MUSCARINIC RECEPTOR BINDING ACTIVITY	Empty organism	PROCYANIDIN B-2
366186	PHARMACOLOGY OF COMPOUND - IN VITRO	CALCIUM CHANNEL BINDING EFFECT	Empty organism	PROCYANIDIN B-2
366187	PHARMACOLOGY OF COMPOUND - IN VITRO	SULFONYLUREA RECEPTOR BINDING ACTIVITY	Empty organism	PROCYANIDIN B-2
366188	PHARMACOLOGY OF COMPOUND - IN VITRO	ADENOSINE A-1 RECEPTOR BINDING INHIBITION	Empty organism	PROCYANIDIN B-2
366189	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	PROCYANIDIN B-2
366190	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	PROCYANIDIN B-2
366191	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-1)	Empty organism	PROCYANIDIN B-2
366192	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-2)	Empty organism	PROCYANIDIN B-2
366193	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(BETA)	Empty organism	PROCYANIDIN B-2
366194	PHARMACOLOGY OF COMPOUND - IN VITRO	ATP-ASE (NA+/K+) BINDING ACTIVITY	Empty organism	PROCYANIDIN B-3
366195	PHARMACOLOGY OF COMPOUND - IN VITRO	SPHINGOMYELINASE INHIBITION	Empty organism	PROCYANIDIN B-3
366196	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZODIAZEPINE BINDING INHIBITION	Empty organism	PROCYANIDIN B-3
366197	PHARMACOLOGY OF COMPOUND - IN VITRO	OPIATE RECEPTOR BINDING INHIBITION	Empty organism	PROCYANIDIN B-3
366198	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	PROCYANIDIN B-3
366199	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	PROCYANIDIN B-3
366200	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	PROCYANIDIN B-3
366201	PHARMACOLOGY OF COMPOUND - IN VITRO	MUSCARINIC RECEPTOR BINDING ACTIVITY	Empty organism	PROCYANIDIN B-3
366202	PHARMACOLOGY OF COMPOUND - IN VITRO	CALCIUM CHANNEL BINDING EFFECT	Empty organism	PROCYANIDIN B-3
366203	PHARMACOLOGY OF COMPOUND - IN VITRO	SULFONYLUREA RECEPTOR BINDING ACTIVITY	Empty organism	PROCYANIDIN B-3
366204	PHARMACOLOGY OF COMPOUND - IN VITRO	ADENOSINE A-1 RECEPTOR BINDING INHIBITION	Empty organism	PROCYANIDIN B-3
366205	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	PROCYANIDIN B-3
366206	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	PROCYANIDIN B-3
366207	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-1)	Empty organism	PROCYANIDIN B-3
366208	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-2)	Empty organism	PROCYANIDIN B-3
366209	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(BETA)	Empty organism	PROCYANIDIN B-3
366210	PHARMACOLOGY OF COMPOUND - IN VITRO	ATP-ASE (NA+/K+) BINDING ACTIVITY	Empty organism	PROCYANIDIN B-4
366211	PHARMACOLOGY OF COMPOUND - IN VITRO	SPHINGOMYELINASE INHIBITION	Empty organism	PROCYANIDIN B-4
366212	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZODIAZEPINE BINDING INHIBITION	Empty organism	PROCYANIDIN B-4
366213	PHARMACOLOGY OF COMPOUND - IN VITRO	OPIATE RECEPTOR BINDING INHIBITION	Empty organism	PROCYANIDIN B-4
366214	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	PROCYANIDIN B-4
366215	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	PROCYANIDIN B-4
366216	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	PROCYANIDIN B-4
366217	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	PROCYANIDIN B-4
366218	PHARMACOLOGY OF COMPOUND - IN VITRO	MUSCARINIC RECEPTOR BINDING ACTIVITY	Empty organism	PROCYANIDIN B-4
366219	PHARMACOLOGY OF COMPOUND - IN VITRO	CALCIUM CHANNEL BINDING EFFECT	Empty organism	PROCYANIDIN B-4
366220	PHARMACOLOGY OF COMPOUND - IN VITRO	SULFONYLUREA RECEPTOR BINDING ACTIVITY	Empty organism	PROCYANIDIN B-4
366221	PHARMACOLOGY OF COMPOUND - IN VITRO	ADENOSINE A-1 RECEPTOR BINDING INHIBITION	Empty organism	PROCYANIDIN B-4
366222	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	PROCYANIDIN B-4
366223	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	PROCYANIDIN B-4
366224	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-1)	Empty organism	PROCYANIDIN B-4
366225	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-2)	Empty organism	PROCYANIDIN B-4
366226	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(BETA)	Empty organism	PROCYANIDIN B-4
366227	PHARMACOLOGY OF COMPOUND - IN VITRO	ATP-ASE (NA+/K+) BINDING ACTIVITY	Empty organism	GALLOYL-BETA-D-GLUCOSE,2-4-DI-O:
366228	PHARMACOLOGY OF COMPOUND - IN VITRO	SPHINGOMYELINASE INHIBITION	Empty organism	GALLOYL-BETA-D-GLUCOSE,2-4-DI-O:
366229	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZODIAZEPINE BINDING INHIBITION	Empty organism	GALLOYL-BETA-D-GLUCOSE,2-4-DI-O:
366230	PHARMACOLOGY OF COMPOUND - IN VITRO	OPIATE RECEPTOR BINDING INHIBITION	Empty organism	GALLOYL-BETA-D-GLUCOSE,2-4-DI-O:
366231	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,2-4-DI-O:
366232	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,2-4-DI-O:
366233	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,2-4-DI-O:
366234	PHARMACOLOGY OF COMPOUND - IN VITRO	MUSCARINIC RECEPTOR BINDING ACTIVITY	Empty organism	GALLOYL-BETA-D-GLUCOSE,2-4-DI-O:
366235	PHARMACOLOGY OF COMPOUND - IN VITRO	CALCIUM CHANNEL BINDING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,2-4-DI-O:
366236	PHARMACOLOGY OF COMPOUND - IN VITRO	SULFONYLUREA RECEPTOR BINDING ACTIVITY	Empty organism	GALLOYL-BETA-D-GLUCOSE,2-4-DI-O:
366237	PHARMACOLOGY OF COMPOUND - IN VITRO	ADENOSINE A-1 RECEPTOR BINDING INHIBITION	Empty organism	GALLOYL-BETA-D-GLUCOSE,2-4-DI-O:
366238	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,2-4-DI-O:
366239	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,2-4-DI-O:
366240	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-1)	Empty organism	GALLOYL-BETA-D-GLUCOSE,2-4-DI-O:
366241	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-2)	Empty organism	GALLOYL-BETA-D-GLUCOSE,2-4-DI-O:
366242	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(BETA)	Empty organism	GALLOYL-BETA-D-GLUCOSE,2-4-DI-O:
366243	PHARMACOLOGY OF COMPOUND - IN VITRO	ATP-ASE (NA+/K+) BINDING ACTIVITY	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-6-TRI-O:
366244	PHARMACOLOGY OF COMPOUND - IN VITRO	SPHINGOMYELINASE INHIBITION	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-6-TRI-O:
366245	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZODIAZEPINE BINDING INHIBITION	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-6-TRI-O:
366246	PHARMACOLOGY OF COMPOUND - IN VITRO	OPIATE RECEPTOR BINDING INHIBITION	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-6-TRI-O:
366247	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-6-TRI-O:
366248	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-6-TRI-O:
366249	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-6-TRI-O:
366250	PHARMACOLOGY OF COMPOUND - IN VITRO	MUSCARINIC RECEPTOR BINDING ACTIVITY	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-6-TRI-O:
366251	PHARMACOLOGY OF COMPOUND - IN VITRO	CALCIUM CHANNEL BINDING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-6-TRI-O:
366252	PHARMACOLOGY OF COMPOUND - IN VITRO	SULFONYLUREA RECEPTOR BINDING ACTIVITY	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-6-TRI-O:
366253	PHARMACOLOGY OF COMPOUND - IN VITRO	ADENOSINE A-1 RECEPTOR BINDING INHIBITION	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-6-TRI-O:
366254	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-6-TRI-O:
366255	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-6-TRI-O:
366256	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-1)	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-6-TRI-O:
366257	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-2)	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-6-TRI-O:
366258	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(BETA)	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-6-TRI-O:
366259	PHARMACOLOGY OF COMPOUND - IN VITRO	ATP-ASE (NA+/K+) BINDING ACTIVITY	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-6-TRI-O:GALLOYL-BETA-D-GLUCOSE,1-3-6-TRI-O:
366260	PHARMACOLOGY OF COMPOUND - IN VITRO	SPHINGOMYELINASE INHIBITION	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-3-6-TRI-O:
366261	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZODIAZEPINE BINDING INHIBITION	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-3-6-TRI-O:
366262	PHARMACOLOGY OF COMPOUND - IN VITRO	OPIATE RECEPTOR BINDING INHIBITION	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-3-6-TRI-O:
366263	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-3-6-TRI-O:
366264	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-3-6-TRI-O:
366265	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-3-6-TRI-O:
366266	PHARMACOLOGY OF COMPOUND - IN VITRO	MUSCARINIC RECEPTOR BINDING ACTIVITY	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-3-6-TRI-O:
366267	PHARMACOLOGY OF COMPOUND - IN VITRO	CALCIUM CHANNEL BINDING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-3-6-TRI-O:
366268	PHARMACOLOGY OF COMPOUND - IN VITRO	SULFONYLUREA RECEPTOR BINDING ACTIVITY	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-3-6-TRI-O:
366269	PHARMACOLOGY OF COMPOUND - IN VITRO	ADENOSINE A-1 RECEPTOR BINDING INHIBITION	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-3-6-TRI-O:
366270	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-3-6-TRI-O:
366271	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-3-6-TRI-O:
366272	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-2)	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-3-6-TRI-O:
366273	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-2)	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-3-6-TRI-O:
366274	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(BETA)	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-3-6-TRI-O:
366275	PHARMACOLOGY OF COMPOUND - IN VITRO	ATP-ASE (NA+/K+) BINDING ACTIVITY	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-4-6-TETRA-O:
366276	PHARMACOLOGY OF COMPOUND - IN VITRO	SPHINGOMYELINASE INHIBITION	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-4-6-TETRA-O:
366277	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZODIAZEPINE BINDING INHIBITION	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-4-6-TETRA-O:
366278	PHARMACOLOGY OF COMPOUND - IN VITRO	OPIATE RECEPTOR BINDING INHIBITION	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-4-6-TETRA-O:
366279	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-4-6-TETRA-O:
366280	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-4-6-TETRA-O:
366281	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-4-6-TETRA-O:
366282	PHARMACOLOGY OF COMPOUND - IN VITRO	MUSCARINIC RECEPTOR BINDING ACTIVITY	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-4-6-TETRA-O:
366283	PHARMACOLOGY OF COMPOUND - IN VITRO	CALCIUM CHANNEL BINDING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-4-6-TETRA-O:
366284	PHARMACOLOGY OF COMPOUND - IN VITRO	SULFONYLUREA RECEPTOR BINDING ACTIVITY	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-4-6-TETRA-O:
366285	PHARMACOLOGY OF COMPOUND - IN VITRO	ADENOSINE A-1 RECEPTOR BINDING INHIBITION	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-4-6-TETRA-O:
366286	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-4-6-TETRA-O:
366287	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-4-6-TETRA-O:
366288	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-1)	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-4-6-TETRA-O:
366289	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-2)	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-4-6-TETRA-O:
366290	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(BETA)	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-4-6-TETRA-O:
366291	PHARMACOLOGY OF COMPOUND - IN VITRO	ATP-ASE (NA+/K+) BINDING ACTIVITY	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
366292	PHARMACOLOGY OF COMPOUND - IN VITRO	SPHINGOMYELINASE INHIBITION	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
366293	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZODIAZEPINE BINDING INHIBITION	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
366294	PHARMACOLOGY OF COMPOUND - IN VITRO	OPIATE RECEPTOR BINDING INHIBITION	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
366295	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
366296	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
366297	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
366298	PHARMACOLOGY OF COMPOUND - IN VITRO	MUSCARINIC RECEPTOR BINDING ACTIVITY	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
366299	PHARMACOLOGY OF COMPOUND - IN VITRO	CALCIUM CHANNEL BINDING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
366300	PHARMACOLOGY OF COMPOUND - IN VITRO	SULFONYLUREA RECEPTOR BINDING ACTIVITY	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
366301	PHARMACOLOGY OF COMPOUND - IN VITRO	ADENOSINE A-1 RECEPTOR BINDING INHIBITION	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
366302	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
366303	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
366304	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-1)	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
366305	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-2)	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
366306	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(BETA)	Empty organism	GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
366307	PHARMACOLOGY OF COMPOUND - IN VITRO	ATP-ASE (NA+/K+) BINDING ACTIVITY	Empty organism	TELLIMAGRANDIN I
366308	PHARMACOLOGY OF COMPOUND - IN VITRO	SPHINGOMYELINASE INHIBITION	Empty organism	TELLIMAGRANDIN I
366309	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZODIAZEPINE BINDING INHIBITION	Empty organism	TELLIMAGRANDIN I
366310	PHARMACOLOGY OF COMPOUND - IN VITRO	OPIATE RECEPTOR BINDING INHIBITION	Empty organism	TELLIMAGRANDIN I
366311	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	TELLIMAGRANDIN I
366312	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	TELLIMAGRANDIN I
366313	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	TELLIMAGRANDIN I
366314	PHARMACOLOGY OF COMPOUND - IN VITRO	MUSCARINIC RECEPTOR BINDING ACTIVITY	Empty organism	TELLIMAGRANDIN I
366315	PHARMACOLOGY OF COMPOUND - IN VITRO	CALCIUM CHANNEL BINDING EFFECT	Empty organism	TELLIMAGRANDIN I
366316	PHARMACOLOGY OF COMPOUND - IN VITRO	SULFONYLUREA RECEPTOR BINDING ACTIVITY	Empty organism	TELLIMAGRANDIN I
366317	PHARMACOLOGY OF COMPOUND - IN VITRO	ADENOSINE A-1 RECEPTOR BINDING INHIBITION	Empty organism	TELLIMAGRANDIN I
366318	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	TELLIMAGRANDIN I
366319	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	TELLIMAGRANDIN I
366320	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-1)	Empty organism	TELLIMAGRANDIN I
366321	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-2)	Empty organism	TELLIMAGRANDIN I
366322	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(BETA)	Empty organism	TELLIMAGRANDIN I
366323	PHARMACOLOGY OF COMPOUND - IN VITRO	ATP-ASE (NA+/K+) BINDING ACTIVITY	Empty organism	PEDUNCULAGIN
366324	PHARMACOLOGY OF COMPOUND - IN VITRO	SPHINGOMYELINASE INHIBITION	Empty organism	PEDUNCULAGIN
366325	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZODIAZEPINE BINDING INHIBITION	Empty organism	PEDUNCULAGIN
366326	PHARMACOLOGY OF COMPOUND - IN VITRO	OPIATE RECEPTOR BINDING INHIBITION	Empty organism	PEDUNCULAGIN
366327	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	PEDUNCULAGIN
366328	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	PEDUNCULAGIN
366329	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	PEDUNCULAGIN
366330	PHARMACOLOGY OF COMPOUND - IN VITRO	MUSCARINIC RECEPTOR BINDING ACTIVITY	Empty organism	PEDUNCULAGIN
366331	PHARMACOLOGY OF COMPOUND - IN VITRO	CALCIUM CHANNEL BINDING EFFECT	Empty organism	PEDUNCULAGIN
366332	PHARMACOLOGY OF COMPOUND - IN VITRO	SULFONYLUREA RECEPTOR BINDING ACTIVITY	Empty organism	PEDUNCULAGIN
366333	PHARMACOLOGY OF COMPOUND - IN VITRO	ADENOSINE A-1 RECEPTOR BINDING INHIBITION	Empty organism	PEDUNCULAGIN
366334	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	PEDUNCULAGIN
366335	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	PEDUNCULAGIN
366336	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-1)	Empty organism	PEDUNCULAGIN
366337	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-2)	Empty organism	PEDUNCULAGIN
366338	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(BETA)	Empty organism	PEDUNCULAGIN
366339	PHARMACOLOGY OF COMPOUND - IN VITRO	ATP-ASE (NA+/K+) BINDING ACTIVITY	Empty organism	DAVIDIIN
366340	PHARMACOLOGY OF COMPOUND - IN VITRO	SPHINGOMYELINASE INHIBITION	Empty organism	DAVIDIIN
366341	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZODIAZEPINE BINDING INHIBITION	Empty organism	DAVIDIIN
366342	PHARMACOLOGY OF COMPOUND - IN VITRO	OPIATE RECEPTOR BINDING INHIBITION	Empty organism	DAVIDIIN
366343	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	DAVIDIIN
366344	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	DAVIDIIN
366345	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	DAVIDIIN
366346	PHARMACOLOGY OF COMPOUND - IN VITRO	MUSCARINIC RECEPTOR BINDING ACTIVITY	Empty organism	DAVIDIIN
366347	PHARMACOLOGY OF COMPOUND - IN VITRO	CALCIUM CHANNEL BINDING EFFECT	Empty organism	DAVIDIIN
366348	PHARMACOLOGY OF COMPOUND - IN VITRO	SULFONYLUREA RECEPTOR BINDING ACTIVITY	Empty organism	DAVIDIIN
366349	PHARMACOLOGY OF COMPOUND - IN VITRO	ADENOSINE A-1 RECEPTOR BINDING INHIBITION	Empty organism	DAVIDIIN
366350	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	DAVIDIIN
366351	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	DAVIDIIN
366352	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-1)	Empty organism	DAVIDIIN
366353	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-2)	Empty organism	DAVIDIIN
366354	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(BETA)	Empty organism	DAVIDIIN
366355	PHARMACOLOGY OF COMPOUND - IN VITRO	ATP-ASE (NA+/K+) BINDING ACTIVITY	Empty organism	GERANIIN
366356	PHARMACOLOGY OF COMPOUND - IN VITRO	SPHINGOMYELINASE INHIBITION	Empty organism	GERANIIN
366357	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZODIAZEPINE BINDING INHIBITION	Empty organism	GERANIIN
366358	PHARMACOLOGY OF COMPOUND - IN VITRO	OPIATE RECEPTOR BINDING INHIBITION	Empty organism	GERANIIN
366359	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GERANIIN
366360	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GERANIIN
366361	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	GERANIIN
366362	PHARMACOLOGY OF COMPOUND - IN VITRO	MUSCARINIC RECEPTOR BINDING ACTIVITY	Empty organism	GERANIIN
366363	PHARMACOLOGY OF COMPOUND - IN VITRO	CALCIUM CHANNEL BINDING EFFECT	Empty organism	GERANIIN
366364	PHARMACOLOGY OF COMPOUND - IN VITRO	SULFONYLUREA RECEPTOR BINDING ACTIVITY	Empty organism	GERANIIN
366365	PHARMACOLOGY OF COMPOUND - IN VITRO	ADENOSINE A-1 RECEPTOR BINDING INHIBITION	Empty organism	GERANIIN
366366	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	GERANIIN
366367	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-1)	Empty organism	GERANIIN
366368	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-2)	Empty organism	GERANIIN
366369	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(BETA)	Empty organism	GERANIIN
366370	PHARMACOLOGY OF COMPOUND - IN VITRO	ATP-ASE (NA+/K+) BINDING ACTIVITY	Empty organism	RUGUSIN D
366371	PHARMACOLOGY OF COMPOUND - IN VITRO	SPHINGOMYELINASE INHIBITION	Empty organism	RUGUSIN D
366372	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZODIAZEPINE BINDING INHIBITION	Empty organism	RUGUSIN D
366373	PHARMACOLOGY OF COMPOUND - IN VITRO	OPIATE RECEPTOR BINDING INHIBITION	Empty organism	RUGUSIN D
366374	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	RUGUSIN D
366375	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	RUGUSIN D
366376	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Empty organism	RUGUSIN D
366377	PHARMACOLOGY OF COMPOUND - IN VITRO	MUSCARINIC RECEPTOR BINDING ACTIVITY	Empty organism	RUGUSIN D
366378	PHARMACOLOGY OF COMPOUND - IN VITRO	CALCIUM CHANNEL BINDING EFFECT	Empty organism	RUGUSIN D
366379	PHARMACOLOGY OF COMPOUND - IN VITRO	SULFONYLUREA RECEPTOR BINDING ACTIVITY	Empty organism	RUGUSIN D
366380	PHARMACOLOGY OF COMPOUND - IN VITRO	ADENOSINE A-1 RECEPTOR BINDING INHIBITION	Empty organism	RUGUSIN D
366381	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	RUGUSIN D
366382	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE RECEPTOR BLOCKING EFFECT	Empty organism	RUGUSIN D
366383	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-1)	Empty organism	RUGUSIN D
366384	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(ALPHA-2)	Empty organism	RUGUSIN D
366385	PHARMACOLOGY OF COMPOUND - IN VITRO	ADRENERGIC RECEPTOR BLOCKER(BETA)	Empty organism	RUGUSIN D

Organism 101348 -

Organism Details

Experiments

Filters

Pharmacology (13)

Compounds (20)

Show SPARQL Queries (1)

Query 1